Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocrystalline megestrol in malnourished first-line NSCLC
NCT06828757Phase 3Not yet recruiting
- Sponsor
- Hunan Cancer Hospital
- Start
- May 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of megestrol in Malnutrition, anorexia-cachexia syndrome (ACS), sponsored by Hunan Cancer Hospital. Planned start May 2025; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
Malnutritionanorexia-cachexia syndrome (ACS)
Beyond the preview
Go deeper on NCT06828757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06828757.